A Comparative Study of the Effect of Two Partographs on the Cesarean Section Rate in Women in Spontaneous Labour (PARTODYS)

October 5, 2021 updated by: University Hospital, Strasbourg, France

In the 2010-french perinatal survey, the overall cesarean section (CS) rate during labour was 21 % and 16% to 38% in case of dystocia.

The definition of " dystocia " is traditionally based on the research led by Friedman in the 1950's on a restricted population sample. Several studies over the last years seem to indicate that the different phases of labour are longer than originally described by Friedman.

Our current hypothesis is that the application of a new definition of dystocia would enable a more appropriate management of labour.

Study Overview

Detailed Description

The main purpose of this study is to show a significant decrease of the CS rate with the use of the new partograph developed by Neal and Lowe.

Secondary purposes are

  • To reduce the use of oxytocin during labour without increasing maternal or neonatal morbidity;
  • To decrease immediate per-operative complications and post-operative complications associated with CS

Study Type

Interventional

Enrollment (Actual)

633

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Strasbourg, France, 67098
        • University Strasbourg Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

Age ≥ 18 years

  • Affiliation to a social security insurance
  • Written consent given
  • Singleton pregnancy
  • Cephalic presentation
  • ≥37 gestational weeks
  • Spontaneous onset of labour

Exclusion Criteria:

  • Previous cesarean section
  • Induction of labour
  • Intrauterine growth restriction
  • In utero fetal death
  • Congenital malformation
  • Chorioamnionitis
  • Placenta praevia
  • Need for an emergency delivery (fetal heart rate abnormalities at admission)
  • Contra-indication for vaginal delivery
  • Patient under temporary guardianship, guardianship or judicial protection
  • Patient included in another study which could interfere with the results of this study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Classical partograph
Labour dystocia is diagnosed when cervical dilation is less than 1 cm per hour or after 3 hours at complete cervical dilation without engagement of the presentation. In this case, active management of labour is started with introduction of oxytocin, artificial rupture of membranes and supportive therapy.
Classical partograph used as standard care
Experimental: New partograph
The second strategy is based on the partograph developped by Neal and Lowe. An active management of labour is started when crossing the dystocia line or when there are no cervical modifications after 4 hours beyond 5 cm of cervical dilation. In this case, active management of labour is started with introduction of oxytocin, artificial rupture of membranes and supportive therapy.

The partograph designed by Neal and Lowe includes an "action line" which if crossed permits an active management of labour.

Eventually, the only difference between the two arms is the moment when the active management of labour is started.

The oxytocin is administrated according to the department protocol.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Cesarean section rate (all causes)
Time Frame: From admission in the labour ward to the delivery (duration from 0 to 24 hours approximately)
From admission in the labour ward to the delivery (duration from 0 to 24 hours approximately)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
obstetrical measures associated with possible effects of both strategies on maternal and fetal outcome
Time Frame: From the admission in the labour ward until the dismissal from maternity (2 to 5 days)
Total amount of oxytocin used (mUI)
From the admission in the labour ward until the dismissal from maternity (2 to 5 days)
obstetrical measures associated with possible effects of both strategies on maternal and fetal outcome
Time Frame: From the admission in the labour ward until the dismissal from maternity (2 to 5 days)
Rate of uterine hyperstimulation (%)
From the admission in the labour ward until the dismissal from maternity (2 to 5 days)
obstetrical measures associated with possible effects of both strategies on maternal and fetal outcome
Time Frame: From the admission in the labour ward until the dismissal from maternity (2 to 5 days)
Rate of post-partum hemorrhage (%)
From the admission in the labour ward until the dismissal from maternity (2 to 5 days)
obstetrical measures associated with possible effects of both strategies on maternal and fetal outcome
Time Frame: From the admission in the labour ward until the dismissal from maternity (2 to 5 days)
Rate of uterine rupture (%)
From the admission in the labour ward until the dismissal from maternity (2 to 5 days)
obstetrical measures associated with possible effects of both strategies on maternal and fetal outcome
Time Frame: From the admission in the labour ward until the dismissal from maternity (2 to 5 days)
Rate of retained placenta (%)
From the admission in the labour ward until the dismissal from maternity (2 to 5 days)
obstetrical measures associated with possible effects of both strategies on maternal and fetal outcome
Time Frame: From the admission in the labour ward until the dismissal from maternity (2 to 5 days)
Need of an artificial rupture of membranes (Y/N)
From the admission in the labour ward until the dismissal from maternity (2 to 5 days)
obstetrical measures associated with possible effects of both strategies on maternal and fetal outcome
Time Frame: From the admission in the labour ward until the dismissal from maternity (2 to 5 days)
Color of the amniotic fluid
From the admission in the labour ward until the dismissal from maternity (2 to 5 days)
obstetrical measures associated with possible effects of both strategies on maternal and fetal outcome
Time Frame: From the admission in the labour ward until the dismissal from maternity (2 to 5 days)
Duration of the first and second stages of labour
From the admission in the labour ward until the dismissal from maternity (2 to 5 days)
obstetrical measures associated with possible effects of both strategies on maternal and fetal outcome
Time Frame: From the admission in the labour ward until the dismissal from maternity (2 to 5 days)
Rate of vaginal delivery (spontaneous or assisted) (%)
From the admission in the labour ward until the dismissal from maternity (2 to 5 days)
obstetrical measures associated with possible effects of both strategies on maternal and fetal outcome
Time Frame: From the admission in the labour ward until the dismissal from maternity (2 to 5 days)
Rate of cesarean section (according to indication) (%)
From the admission in the labour ward until the dismissal from maternity (2 to 5 days)
Maternal measures associated with possible effects of both strategies on maternal and fetal outcome
Time Frame: From the admission in the labour ward until the dismissal from maternity (2 to 5 days)
Need for an epidural or general anaesthesia
From the admission in the labour ward until the dismissal from maternity (2 to 5 days)
Maternal measures associated with possible effects of both strategies on maternal and fetal outcome
Time Frame: From the admission in the labour ward until the dismissal from maternity (2 to 5 days)
Transfusion rate (%)
From the admission in the labour ward until the dismissal from maternity (2 to 5 days)
Maternal measures associated with possible effects of both strategies on maternal and fetal outcome
Time Frame: From the admission in the labour ward until the dismissal from maternity (2 to 5 days)
Maternal fever during labour (°C)
From the admission in the labour ward until the dismissal from maternity (2 to 5 days)
Maternal measures associated with possible effects of both strategies on maternal and fetal outcome
Time Frame: From the admission in the labour ward until the dismissal from maternity (2 to 5 days)
Rate of thrombo-embolic events (%)
From the admission in the labour ward until the dismissal from maternity (2 to 5 days)
Maternal measures associated with possible effects of both strategies on maternal and fetal outcome
Time Frame: From the admission in the labour ward until the dismissal from maternity (2 to 5 days)
Rate of third- and fourth-degree perineal tears and episiotomy (%)
From the admission in the labour ward until the dismissal from maternity (2 to 5 days)
Maternal measures associated with possible effects of both strategies on maternal and fetal outcome
Time Frame: From the admission in the labour ward until the dismissal from maternity (2 to 5 days)
Rate of surgical site infection, endometritis or septicemia (%)
From the admission in the labour ward until the dismissal from maternity (2 to 5 days)
Neonatal measures associated with possible effects of both strategies on maternal and fetal outcome
Time Frame: From the admission in the labour ward until the dismissal from maternity (2 to 5 days)
Neonatal arterial umbilical cord pH < 7,00 and/or BD > 12 mmol/L
From the admission in the labour ward until the dismissal from maternity (2 to 5 days)
Neonatal measures associated with possible effects of both strategies on maternal and fetal outcome
Time Frame: From the admission in the labour ward until the dismissal from maternity (2 to 5 days)
Apgar score < 7 at 5 minutes
From the admission in the labour ward until the dismissal from maternity (2 to 5 days)
Neonatal measures associated with possible effects of both strategies on maternal and fetal outcome
Time Frame: From the admission in the labour ward until the dismissal from maternity (2 to 5 days)
Transfer to intensive care unit rate
From the admission in the labour ward until the dismissal from maternity (2 to 5 days)
Neonatal measures associated with possible effects of both strategies on maternal and fetal outcome
Time Frame: From the admission in the labour ward until the dismissal from maternity (2 to 5 days)
Neonatal infection rate (%)
From the admission in the labour ward until the dismissal from maternity (2 to 5 days)
Neonatal measures associated with possible effects of both strategies on maternal and fetal outcome
Time Frame: From the admission in the labour ward until the dismissal from maternity (2 to 5 days)
Neonatal convulsion rate (%)
From the admission in the labour ward until the dismissal from maternity (2 to 5 days)
Neonatal measures associated with possible effects of both strategies on maternal and fetal outcome
Time Frame: From the admission in the labour ward until the dismissal from maternity (2 to 5 days)
Rate of neonatal deaths (%)
From the admission in the labour ward until the dismissal from maternity (2 to 5 days)
Neonatal measures associated with possible effects of both strategies on maternal and fetal outcome
Time Frame: From the admission in the labour ward until the dismissal from maternity (2 to 5 days)
Neonatal encephalopathy rate (or the introduction of therapeutic hypothermia)
From the admission in the labour ward until the dismissal from maternity (2 to 5 days)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Adrien GAUDINEAU, Strasbourg's University Hospitals

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 21, 2016

Primary Completion (Actual)

October 7, 2019

Study Completion (Actual)

October 7, 2019

Study Registration Dates

First Submitted

January 12, 2016

First Submitted That Met QC Criteria

April 15, 2016

First Posted (Estimate)

April 18, 2016

Study Record Updates

Last Update Posted (Actual)

October 14, 2021

Last Update Submitted That Met QC Criteria

October 5, 2021

Last Verified

October 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • 6225

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dystocia

Clinical Trials on Classical partograph

Subscribe